Valuation: Novartis AG

Market Cap 278B 244B 225B 207B 391B 26,821B 397B 2,694B 1,056B 13,123B 1,044B 1,022B 45,213B P/E 2026 *
21.2x
P/E 2027 * 18x
Enterprise Value 310B 272B 251B 231B 436B 29,906B 443B 3,004B 1,178B 14,633B 1,165B 1,139B 50,414B EV / Sales 2026 *
5.45x
EV / Sales 2027 * 5.08x
Free-Float
91.66%
Yield 2026 *
2.93%
Yield 2027 * 3.02%
1 day-1.52%
1 week-1.19%
Current month-2.75%
1 month+4.06%
3 months+4.13%
6 months+7.74%
Current year+12.32%
1 week 121.06
Extreme 121.06
125.36
1 month 117.96
Extreme 117.96
128.92
Current year 107.68
Extreme 107.68
131
1 year 91.3
Extreme 91.3
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
5/18/26 A Sell -5,200 0.0003%
5/4/26 A Sell 6,800 0.0003%
2/17/26 A Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%-1.19%+33.38%+35.35% 284B
-2.73%-2.96%+48.62%+147.27% 1,051B
-1.67%-3.47%+52.00%+47.77% 609B
-0.44%+2.17%+33.88%+78.20% 450B
-0.75%+0.30%+28.32%+21.15% 330B
-1.70%-1.82%+20.26%+15.74% 263B
-0.58%+1.11%-20.89%-40.59% 223B
-0.58%+1.03%+23.55%+56.14% 198B
-0.80%+1.38%+23.09%+66.64% 167B
-1.20%+1.10%+1.14%-32.69% 143B
Average -0.80%-0.03%+24.34%+39.50% 371.78B
Weighted average by Cap. -0.90%-0.99%+33.94%+66.90%

Financials

2026 *2027 *
Net sales 56.91B 49.88B 46.1B 42.4B 80.01B 5,487B 81.29B 551B 216B 2,685B 214B 209B 9,250B 60.31B 52.86B 48.86B 44.94B 84.79B 5,816B 86.16B 584B 229B 2,846B 226B 222B 9,804B
Net income 14.08B 12.34B 11.41B 10.49B 19.79B 1,358B 20.11B 136B 53.47B 664B 52.87B 51.71B 2,289B 15.64B 13.71B 12.67B 11.66B 21.99B 1,508B 22.35B 152B 59.41B 738B 58.74B 57.46B 2,543B
Net Debt 32B 28.05B 25.92B 23.84B 44.99B 3,086B 45.71B 310B 122B 1,510B 120B 118B 5,201B 28.48B 24.96B 23.07B 21.22B 40.04B 2,746B 40.68B 276B 108B 1,344B 107B 105B 4,630B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
20/07/26 CHF 123.10 -1.52% 1,700,014
17/07/26 CHF 125.00 +1.41% 2,979,184
16/07/26 CHF 123.26 +1.03% 2,306,603
15/07/26 CHF 122.00 -0.34% 1,730,393
14/07/26 CHF 122.42 -1.73% 2,431,098
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
151.94USD
Average target price
152.73USD
Spread / Average Target
+0.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock